dw.com
Neutraldw.com Β· Β· DE
Ebola: Why is there still no vaccine?
Executive Summary
AI-generatedThe article describes a public health crisis and a scientific/ethical roadblock to vaccine deployment, lacking any concrete commercial mechanism such as investment, price change, or regulatory action that would trigger a sector impact.
Key Insights
- Major outbreak of Bundibugyo variant of Ebola in DRC
- Over 10,000 cases reported since May in DRC
- No licensed vaccine currently approved for Bundibugyo variant
- Existing vaccine (Ervebo) is only approved for Zaire variant
- Cases also reported in Kenya and Nigeria
Topic context
The full article is on the original publisher site.